Summit Therapeutics Inc. (SMMT) stock analysis

SMMT · Summit Therapeutics Inc.

Latest recorded price: USD 11.82

Sector and industry: Healthcare · Biotechnology

Fiscal 2024 figures: revenue growth -100.0%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare